StonvexLoading…
StonvexStonvexStonvexCore line items from NRGV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $203.67M | $46.20M | $341.54M | $145.88M |
Operating Income | $-74.37M | $-130.00M | $-106.74M | $-63.08M |
Net Income | $-103.61M | $-135.75M | $-98.44M | $-78.30M |
EPS (Diluted) | $-0.65 | $-0.91 | $-0.69 | $-0.64 |
Total Assets | $312.88M | $183.89M | $340.75M | $416.71M |
Total Liabilities | $224.26M | $57.63M | $116.96M | $129.00M |
Cash & Equivalents | $58.26M | $27.09M | $109.92M | $203.04M |
Free Cash Flow OCF − CapEx | $-46.74M | $-114.71M | $-123.09M | $-25.66M |
Shares Outstanding | 168.97M | 153.21M | 146.58M | 138.53M |